The Next Pharma Acquisition (at Motley Fool)

The rate of mergers and acquisitions among drugmakers has reached a feverish pace lately, but I can't see it slowing down anytime soon. Some drugmakers' stock has been beaten down to respectable levels, and the falling dollar has made stateside drugmakers cheaper for foreign counterparts to consider. Which of course leads to the question: Who's next? Partners One of the criteria for a successful acquisition is how informed a company is about the takeover target's business. And you can't get much more involved than when you're working hand-in-hand to develop or sell your takeover target's drug. Here's just a small list of the companies that could be takeover targets: The only problem with partnerships is that they dissuade potential suitors that don't want to buy the rights to half a drug, and it's a little hard to get a... [read full story]